Pfizer Limited (NSE:PFIZER)
4,989.65
-30.35 (-0.60%)
At close: Aug 8, 2025, 3:30 PM IST
New Relic Market Cap
Pfizer has a market cap or net worth of 228.42 billion as of August 8, 2025. Its market cap has decreased by -5.81% in one year.
Market Cap
228.42B
Enterprise Value
201.68B
Revenue
22.81B
Ranking
n/a
PE Ratio
29.76
Stock Price
$4,989.65
Market Cap Chart
Since March 12, 1999, Pfizer's market cap has increased from 33.02B to 228.42B, an increase of 591.85%. That is a compound annual growth rate of 7.59%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 8, 2025 | 228.42B | -5.46% |
Dec 31, 2024 | 241.62B | 23.72% |
Dec 29, 2023 | 195.29B | -3.67% |
Dec 30, 2022 | 202.74B | -12.34% |
Dec 31, 2021 | 231.27B | -1.01% |
Dec 31, 2020 | 233.62B | 20.88% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Sun Pharmaceutical Industries | 3,835.10B |
Divi's Laboratories | 1,628.25B |
Cipla | 1,204.36B |
Mankind Pharma | 1,055.02B |
Apollo Hospitals Enterprise | 1,030.94B |
Zydus Lifesciences | 938.51B |
Fortis Healthcare | 647.87B |
Aurobindo Pharma | 621.23B |